|
US2014243381A1
|
|
Furyl and thienyl triazole derivatives and therapeutic uses thereof
|
|
AU2012261790A1
|
|
Compositions and methods to modulate cell membrane resealing
|
|
WO2013082295A1
|
|
Insulin-mimetics as therapeutic adjuncts for bone regeneration
|
|
US2013065866A1
|
|
Dentinal drug delivery composition and screening method
|
|
US2013131005A1
|
|
Methods and compositions for providing cardiac protection
|
|
US2013101623A1
|
|
Attenuated mycobacterial strain as novel vaccine against tuberculosis
|
|
WO2013089888A2
|
|
Gel-tethered molecular beacons
|
|
AU2012233059A1
|
|
Compositions comprising MG29 nucleic acids, polypeptides and associated methods of use
|
|
US2013022501A1
|
|
Salivary Bioassay for Early Detection of Bone Loss
|
|
EP2753363A2
|
|
Compositions comprising mg53 and methods for the treatment and prevention of airway injury
|
|
WO2013033589A1
|
|
Manual insufflator-exsufflator
|
|
WO2013032879A1
|
|
Targeting podoplanin with lectin for use in the prevention and treatment of cancer
|
|
WO2013028902A2
|
|
Methods of isolating rna and mapping of polyadenylation isoforms
|
|
WO2013023144A2
|
|
Diagnostic biomarker profiles for the detection and diagnosis of parkinsons disease
|
|
WO2013020078A1
|
|
Sequence-specific mrna interferase and uses thereof
|
|
WO2013019881A2
|
|
Improved microfluidic device and method and system for its use
|
|
WO2013016512A1
|
|
Methods and kits for detecting mastitis
|
|
WO2013010003A1
|
|
Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease
|
|
WO2013006798A1
|
|
Vandium compounds as therapeutic adjuncts for cartilage regeneration and repair
|
|
WO2012174126A1
|
|
METHOD OF INHIBITING NONSENSE-MEDIATED mRNA DECAY
|
